Please provide your email address to receive an email when new articles are posted on . The FDA approval of Izervay has provided a second welcomed treatment option for geographic atrophy, with good ...

Mission MSA is proud to announce its 2026 designated MSA Centers of Excellence (COE), a prestigious network of clinical institutions ...

Please provide your email address to receive an email when new articles are posted on . WAILEA, Hawaii — When making treatment decisions for geographic atrophy, atrophy geometry, lesion size and ...

Add Yahoo as a preferred source to see more of our stories on Google. As our bodies undergo hormonal shifts during perimenopause and beyond, symptoms like hot flashes, sleep troubles and mood swings ...

Geographic atrophy is a leading cause of blindness. The new approval will help to fill an unmet need for patients. The first ever treatment for geographic atrophy (GA) was approved by the FDA.

Ocugen, Inc. has completed enrollment in the Phase 2 portion of its clinical trial for OCU410, a novel gene therapy aimed at treating geographic atrophy (GA) associated with dry age-related macular ...

Geographic atrophy (GA) is a chronic, progressive degeneration of the macula that can occur in some people with dry macular degeneration. GA is a late, or advanced, stage of the disease. The people ...

Expert Rev of Obstet Gynecol. 2013;8(5):457-465. While treatments for vulvovaginal atrophy have often focused on the vagina, it is critical to address care for the vulvar vestibule as well. The ...